Whitehawk Therapeutics is an antibody drug conjugate (ADC)-focused oncology therapeutics company that employs an agile and pragmatic strategy to drug development
Whitehawk Therapeutics is an antibody drug conjugate (ADC)-focused oncology therapeutics company that employs an agile and pragmatic strategy to drug development. The company targets high-potential cancer indications with significant patient unmet needs, leveraging advanced ADC technologies and clinical strategies.